Intolerance of uncertainty in opioid dependency - Relationship with trait anxiety and impulsivity

Julia Garami, Paul Haber, Catherine E Myers, Michael T Allen, Blazej Misiak, Dorota Frydecka, Ahmed A Moustafa, Julia Garami, Paul Haber, Catherine E Myers, Michael T Allen, Blazej Misiak, Dorota Frydecka, Ahmed A Moustafa

Abstract

Intolerance of uncertainty (IU) is the tendency to interpret ambiguous situations as threatening and having negative consequences, resulting in feelings of distress and anxiety. IU has been linked to a number of anxiety disorders, and anxiety felt in the face of uncertainty may result in maladaptive behaviors such as impulsive decision making. Although there is strong evidence that anxiety and impulsivity are risk factors for addiction, there is a paucity of research examining the role of IU in this disorder. The rate of opioid addiction, in particular, has been rising steadily in recent years, which necessitates deeper understanding of risk factors in order to develop effective prevention and treatment methods. The current study tested for the first time whether opioid-dependent adults are less tolerant of uncertainty compared to a healthy comparison group. Opioid dependent patients undergoing methadone maintenance therapy (n = 114) and healthy comparisons (n = 69) completed the following scales: Intolerance of Uncertainty Scale, the Barrett Impulsivity Scale, and the State Trait Anxiety Inventory. Analysis revealed that these measures were positively correlated with each other and that opioid-dependent patients had significantly higher IU scores. Regression analysis revealed that anxiety mediated the relationship between IU and impulsivity. Hierarchical moderation regression found an interaction between addiction status and impulsivity on IU scores in that the relationship between these variables was only observed in the patient group. Findings suggest that IU is a feature of addiction but does not necessarily play a unique role. Further research is needed to explore the complex relationship between traits and how they may contribute to the development and maintenance of addiction.

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

References

    1. Jones C, Logan J, Gladden R, Bohm M. Vital signs: Demographic and substance use trends among heroin users—United States, 2002–2013. Morb Mortal Weekly Rep. 2015;64(26):719–25.
    1. European Monitoring Centre for Drugs and Drug Addiction. European Drug Report. Luxembourg: Publications Office of the European Union; 2015.
    1. Roxburgh A, Ritter A, Slade T, Burns L. Trends in drug use and related harms in Australia, 2001 to 2013 Sydney: National Drug and Alcohol Research Centre, University of New South Wales; 2013.
    1. Fishbain DA, Cole B, Lewis J, Rosomoff HL, Rosomoff RS. What percentage of chronic nonmalignant pain patients exposed to chronic opioid analgesic therapy develop abuse/addiction and/or aberrant drug‐related behaviors? A structured evidence‐based review. Pain Med. 2008;9(4):444–59. doi:
    1. Piazza P, Deroche-Gamonet V. A multistep general theory of transition to addiction. Psychopharmacology. 2013;229(3):387–413. doi:
    1. Sinha R. How does stress increase risk of drug abuse and relapse? Psychopharmacology. 2001;158(4):343–59. doi:
    1. Sher KJ, Levenson RW. Risk for alcoholism and individual differences in the stress-response-dampening effect of alcohol. J Abnorm Psychol. 1982;91(5):350–67.
    1. Blum J, Gerber H, Gerhard U, Schmid O, Petitjean S, Riecher-Rössler A, et al. Acute effects of heroin on emotions in heroin-dependent patients. Am J Addiction. 2013;22(6):598–604.
    1. Sheynin J, Moustafa AA, Beck K, Servatius R, Casbolt PA, Haber P, et al. Exaggerated acquisition and resistance to extinction of avoidance behavior in treated heroin- dependent men. J Clin Psychiatry. 2016;77(3):386–94. doi:
    1. Kushner MG, Krueger RK, Frye B, Peterson J. Epidemiological perspectives on co-occuring anxiety disorder and substance use disorder In: Stewart SH, Conrod PJ, editors. Anxiety and substance use disorders: the vicious cycle of comorbidity. New York: New York: Springer; 2008. p. 3–17.
    1. Lai HMX, Cleary M, Sitharthan T, Hunt GE. Prevalence of comorbid substance use, anxiety and mood disorders in epidemiological surveys, 1990–2014: A systematic review and meta-analysis. Drug Alcohol Depend. 2015;154:1–13. doi:
    1. Grant BF, Stinson FS, Dawson DA, Chou SP, Dufour MC, Compton W, et al. Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. Alcohol Res Health. 2004;29(2):107–20.
    1. Litt MD, Cooney NL, Morse P. Reactivity to alcohol‐related stimuli in the laboratory and in the field: predictors of craving in treated alcoholics. Addiction. 2000;95(6):889–900.
    1. Mehroof M, Griffiths MD. Online gaming addiction: The role of sensation seeking, self-control, neuroticism, aggression, state anxiety, and trait anxiety. Cyberpsychol Behav Soc Netw. 2010;13(3):313–6.
    1. Wilsey BL, Fishman SM, Tsodikov A, Ogden C, Symreng I, Ernst A. Psychological comorbidities predicting prescription opioid abuse among patients in chronic pain presenting to the emergency department. Pain Med. 2008;9(8):1107–17. doi:
    1. Grant BF, Goldstein RB, Chou SP, Huang B, Stinson FS, Dawson DA, et al. Sociodemographic and psychopathologic predictors of first incidence of DSM-IV substance use, mood and anxiety disorders: results from the Wave 2 National Epidemiologic Survey on Alcohol and Related Conditions. Mol Psychiatry. 2009;14(11):1051 doi:
    1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders 5ed. Arlington, VA: American Psychiatric Publishing; 2013.
    1. Freeston MH, Rhéaume J, Letarte H, Dugas MJ, Ladouceur R. Why do people worry? Pers and Individ Dif. 1994;17(6):791–802.
    1. Buhr K, Dugas M. The intolerance of uncertainty scale: Psychometric properties of the English version. Behav Res Ther. 2002;40(8):931–45.
    1. Carleton RN, Mulvogue M, Thibodeau MA, McCabe R, Antony MM, Asmundson G. Increasingly certain about uncertainty: Intolerance of uncertainty across anxiety and depression. J Anxiety Disord. 2012;26(3):468–79. doi:
    1. Mahoney AJ, McEvoy P. A transdiagnostic examination of intolerance of uncertainty across anxiety and depressive disorders. Cogn Behav Ther. 2012;41(3):212–22. doi:
    1. McEvoy PM, Mahoney AEJ. To be sure, to be sure: Intolerance of uncertainty mediates symptoms of various anxiety disorders and depression. Behav Ther. 2012;43(3):533–45. doi:
    1. Dugas M, Gagnon F, Ladouceur R, Freeston M. Generalized anxiety disorder: A preliminary test of a conceptual model. Behav Res Ther. 1998;36(2):215–26.
    1. Dugas M, Gosselin P, Ladouceur R. Intolerance of uncertainty and worry: Investigating specificity in a nonclinical sample. Cognit Ther Res. 2001;25(5):551–8.
    1. Khawaja NG, Chapman D. Cognitive predictors of worry in a non‐ clinical population. Clin Psychol. 2007;11(1):24–32.
    1. Meeten F, Dash S, Scarlet A, Davey G. Investigating the effect of intolerance of uncertainty on catastrophic worrying and mood. Behav Res Ther. 2012;50(11):690 doi:
    1. Robinson J, Sareen J, Cox B, Bolton J. Self- medication of anxiety disorders with alcohol and drugs: Results from a nationally representative sample. J Anxiety Disord. 2009;23(1):38–45. doi:
    1. Kraemer K, McLeish A, Bryan E. The role of intolerance of uncertainty in terms of alcohol use motives among college students. Addict Behav. 2015;42:162 doi:
    1. Oglesby M, Albanese B, Chavarria J, Schmidt N. Intolerance of uncertainty in relation to motives for alcohol use. Cogn Ther Res. 2015;39(3):356–65.
    1. Carpenter K, Hasin D. Drinking to cope with negative affect and DSM-IV alcohol use disorders: A test of three alternative explanations. J Stud Alcohol. 1999;60(5):694–704.
    1. Cooper ML, Russell M, Skinner JB, Windle M. Development and validation of a three- dimensional measure of drinking motives. Psychol Assess. 1992;4(2):123–32.
    1. Cooper ML, Frone MR, Russell M, Mudar P. Drinking to regulate positive and negative emotions: A motivational model of alcohol use. J Pers Soc Psychol. 1995;69(5):990–1005.
    1. Park C, Levenson M. Drinking to cope among college students: Prevalence, problems and coping processes. J Stud Alcohol. 2002;63(4):486–97.
    1. Chamorro J, Bernardi S, Marsh R, Wang S, Blanco C, Potenza MN, et al. Impulsivity in the general population: A national study. J Psychiatr Res. 2012;46(8):994–1001. doi:
    1. Ersche KD, Turton AJ, Pradhan S, Bullmore ET, Robbins TW. Drug addiction endophenotypes: Impulsive versus sensation-seeking personality traits. Biol Psychiatry. 2010;68(8):770–3. doi:
    1. Moeller F, Barratt E, Dougherty DM, Schmitz J, Swann A. Psychiatric aspects of impulsivity. Am J Psychiat. 2001;158:1783–93. doi:
    1. Stanford MS, Mathias CW, Dougherty DM, Lake S, Anderson N, Patton J. Fifty years of the Barratt Impulsiveness Scale: An update and review. Pers Individ Differ. 2009;47:385–95.
    1. Winstanley C, Olausson P, Taylor Jr., Jentsch JD. Insight into the relationship between impulsivity and substance abuse from studies using animal models. Alcohol Clin and Exp Res. 2010;34(8):1306–18.
    1. Leland DS, Arce E, Feinstein JS, Paulus MP. Young adult stimulant users increased striatal activation during uncertainty is related to impulsivity. NeuroImage. 2006;33(2):725–31. doi:
    1. Barratt ES. Factor analysis of some psychometric measures of impulsiveness and anxiety. Psychol Rep. 1965;16:547–54. doi:
    1. Maner JK, Schmidt NB. The role of risk avoidance in anxiety. Behav Ther. 2006;37(2):181–9. doi:
    1. Ladouceur R, Talbot F, Dugas MJ. Behavioral expressions of intolerance of uncertainty in worry: Experimental findings. Behav Modif. 1997;21(3):355–71. doi:
    1. Tallis F, Eysenck M, Mathews A. Elevated evidence requirements and worry. Pers Individ Dif. 1991;12(1):21–7.
    1. Metzger RL, Miller ML, Cohen M, Sofka M, Borkovec TD. Worry changes decision making: The effect of negative thoughts on cognitive processing. J Clin Psychol. 1990;46(1):78–88.
    1. Corr P. J. A. Gray's reinforcement sensitivity theory: tests of the joint subsystems hypothesis of anxiety and impulsivity. Pers Individ Dif. 2002;33(4):511–32.
    1. Kashdan TB, Hofmann SG. The high‐noveltynseeking, impulsive subtype of generalized social anxiety disorder. Depress Anxiety. 2008;25(6):535–41. doi:
    1. Cougle JR, Goetz AR, Timpano KR. Exploring the unique and interactive roles of distress tolerance and negative urgency in obsessions. Pers Individ Dif. 2012;52(4):515–20.
    1. Pawluk E, Koerner N. A preliminary investigation of impulsivity in generalized anxiety disorder. Pers Individ Dif. 2013;54(6):732–7.
    1. Nelson B, Kessel E, Jackson F, Hajcak G. The impact of an unpredictable context and intolerance of uncertainty on the electrocortical response to monetary gains and losses. Cogn Affect Behav Neurosci. 2016;16(1):153–63. doi:
    1. Worthy D, Byrne K, Fields S. Effects of emotion on prospection during decision-making. Front In Psychol. 2014;5.
    1. Luhmann C, Ishida K, Hajcak G. Intolerance of uncertainty and decisions about delayed, probabilistic rewards. Behav Ther. 2011;42(3):378 doi:
    1. Patak M, Reynolds B. Question- based assessments of delay discounting: Do respondents spontaneously incorporate uncertainty into their valuations for delayed rewards? Addict Behav. 2007;32(2):351 doi:
    1. Patton JH, Stanford MS, Barratt ES. Factor structure of the Barratt Impulsiveness Scale. J Clin Psychol. 1995;51(6):768–74.
    1. Spielberger CD, Gorusch RL, Lushene R, Vagg PR, Jacobs GA. State-Trait Anxiety Inventory for Adults: Self-Evaluation Questionnaire (STAI Form Y-1 and Form Y-2). Redwood City, CA: Mind Garden; 1977.
    1. Barnes L, Harp D, Jung W. Reliability generalization of scores on the Spielberger State-Trait Anxiety Inventory. Educ Psychol Meas. 2002;62(4):603–18.
    1. Piazza P, Le Moal M. The role of stress in drug self-administration. Trends Pharmacol Sci. 1998;19(2):67–73.
    1. Everitt BJ, Robbins TW. Neural systems of reinforcement for drug addiction: From actions to habits to compulsion. Nat Neurosci. 2005;8(11):1481 doi:
    1. Jacobsen L, Southwick S, Kosten T. Substance use disorders in patients with posttraumatic stress disorder: A review of the literature. Am J Psychiatry. 2001;158(8):1184–90. doi:
    1. Gay P, Schmidt R, Linden M. Impulsivity and Intrusive Thoughts: Related Manifestations of Self- Control Difficulties? Cogn Ther Res. 2011;35(4):293–303.
    1. Belzer K, Zurilla T, Maydeu-Olivares A. Social problem solving and trait anxiety as predictors of worry in a college student population. Pers Individ Dif. 2002;33(4):573–85.
    1. Miller J, Flory K, Lynam D, Leukefeld C. A test of the four- factor model of impulsivity- related traits. Pers Individ Dif. 2003;34(8):1403–18.
    1. Holloway J, Allen M, Myers CE, Servatius R. Behaviorally inhibited individuals demonstrate significantly enhanced conditioned response acquisition under non- optimal learning conditions. Behav Brain Res. 2014;261:49–55. doi:
    1. Allen M, Myers CE, Servatius R. Uncertainty of trial timing enhances acquisition of conditioned eyeblinks in anxiety vulnerable individuals. Behav Brain Res. 2016;304:86–91. doi:
    1. Allen MT, Myers CE, Servatius RJ. Avoidance prone individuals self reporting behavioral inhibition exhibit facilitated acquisition and altered extinction of conditioned eyeblinks with partial reinforcement schedules. Front Behav Neurosci. 2014;8.
    1. Myers CE, Sheynin J, Balsdon T, Luzardo A, Beck K, Hogarth L, et al. Probabilistic reward- and punishment-based learning in opioid addiction: Experimental and computational data. Behav Brain Res. 2016;296:240–8. doi:
    1. Radell M, Myers CE, Beck K, Moustafa AA, Allen MT. The personality trait of intolerance to uncertainty affects behavior in a novel computer-based conditioned place preference task. Front Psychol. 2016;7.
    1. Volkow N, Fowler J, Wang G, Swanson J, Telang F. Dopamine in drug abuse and addiction—Results of imaging studies and treatment implications. Arch Neurol. 2004;9:1575–9.

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe